Skip to main content
[Preprint]. 2023 Nov 1:2023.10.27.564454. [Version 1] doi: 10.1101/2023.10.27.564454

Figure 2. DLBCL immune characterization workflow.

Figure 2.

(A) Peripheral blood was collected from healthy blood donors (n=17) and from patients diagnosed with diffuse large B-cell lymphoma (n=28) before and after chemotherapy. (B) Blood samples were split and analyzed using two mass cytometry panels. Data from each panel was imported separately in MetaGate and later merged.